JP2023504826A5 - - Google Patents
Info
- Publication number
- JP2023504826A5 JP2023504826A5 JP2022533406A JP2022533406A JP2023504826A5 JP 2023504826 A5 JP2023504826 A5 JP 2023504826A5 JP 2022533406 A JP2022533406 A JP 2022533406A JP 2022533406 A JP2022533406 A JP 2022533406A JP 2023504826 A5 JP2023504826 A5 JP 2023504826A5
- Authority
- JP
- Japan
- Prior art keywords
- recombinase
- sequence
- seq
- fusion protein
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19214152.1 | 2019-12-06 | ||
| EP19214152.1A EP3831939A1 (en) | 2019-12-06 | 2019-12-06 | Fusion of site-specific recombinases for efficient and specific genome editing |
| PCT/EP2020/084489 WO2021110846A1 (en) | 2019-12-06 | 2020-12-03 | Fusion of site-specific recombinases for efficient and specific genome editing |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023504826A JP2023504826A (ja) | 2023-02-07 |
| JP2023504826A5 true JP2023504826A5 (cg-RX-API-DMAC7.html) | 2023-07-14 |
| JP7702149B2 JP7702149B2 (ja) | 2025-07-03 |
Family
ID=68808195
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022533406A Active JP7702149B2 (ja) | 2019-12-06 | 2020-12-03 | 効率的かつ特異的なゲノム編集のための部位特異的リコンビナーゼの融合 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250243473A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3831939A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7702149B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN115427558A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020396214B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3163359A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022006799A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021110846A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3638776T3 (pl) | 2017-06-14 | 2026-02-23 | Technische Universität Dresden | Sposoby i środki do zmiany genetycznej genomów z wykorzystaniem projektowanych enzymów rekombinujących dna |
| CA3232485A1 (en) * | 2021-11-15 | 2023-05-19 | Technische Universitat Dresden | Site-specific recombinases for efficient and specific genome editing |
| AU2024363742A1 (en) * | 2023-10-16 | 2026-04-30 | Technische Universität Dresden Körperschaft Des Öffentlichen Rechts | Conditioned dna modifying enzyme comprising heterologous dna binding domain |
| US20260049306A1 (en) | 2024-07-25 | 2026-02-19 | Technische Universität Dresden Körperschaft Des Öffentlichen Rechts | Modifying nucleic acid sequences having asymmetric target sites |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5981830A (en) | 1997-05-30 | 1999-11-09 | Schering Aktiengesellschaft | Knockout mice and their progeny with a disrupted hepsin gene |
| AU745960C (en) * | 1997-11-18 | 2003-09-18 | Pioneer Hi-Bred International, Inc. | A novel method for the integration of foreign DNA into eukaryoticgenomes |
| GB0029375D0 (en) * | 2000-12-01 | 2001-01-17 | Total Fina Elf | Substrate linked directed evolution (slide) |
| US20060014264A1 (en) * | 2004-07-13 | 2006-01-19 | Stowers Institute For Medical Research | Cre/lox system with lox sites having an extended spacer region |
| EP1942192A1 (en) | 2007-01-08 | 2008-07-09 | Heinrich-Pette-Institut für experimentelle Virologie und Immunologie | Use of a tailored recombinase for the treatment of retroviral infections |
| CN103154256A (zh) | 2010-05-27 | 2013-06-12 | 海因里希·佩特研究所莱比锡试验病毒学研究所-民法基金会 | 用于使多种逆转录病毒毒株中的不对称靶位点重组的修整重组酶 |
| CN105531375B (zh) * | 2012-12-10 | 2020-03-03 | 分析生物科学有限公司 | 靶向基因组分析的方法 |
| EP2993229A1 (en) | 2014-09-02 | 2016-03-09 | Heinrich-Pette-Institut Leibniz-Institut für experimentelle Virologie-Stiftung bürgerlichen Rechts - | Well-tolerated and highly specific tailored recombinase for recombining asymmetric target sites in a plurality of retrovirus strains |
| US10017832B2 (en) * | 2015-08-25 | 2018-07-10 | Washington University | Compositions and methods for site specific recombination at asymmetric sites |
| PL3638776T3 (pl) | 2017-06-14 | 2026-02-23 | Technische Universität Dresden | Sposoby i środki do zmiany genetycznej genomów z wykorzystaniem projektowanych enzymów rekombinujących dna |
| IL278546B2 (en) * | 2018-05-09 | 2026-03-01 | Keros Therapeutics Inc | Activin receptor type IIA variants and methods of using them |
-
2019
- 2019-12-06 EP EP19214152.1A patent/EP3831939A1/en not_active Withdrawn
-
2020
- 2020-12-03 EP EP20816214.9A patent/EP4069834A1/en active Pending
- 2020-12-03 JP JP2022533406A patent/JP7702149B2/ja active Active
- 2020-12-03 AU AU2020396214A patent/AU2020396214B2/en active Active
- 2020-12-03 CA CA3163359A patent/CA3163359A1/en active Pending
- 2020-12-03 US US17/780,136 patent/US20250243473A1/en active Pending
- 2020-12-03 WO PCT/EP2020/084489 patent/WO2021110846A1/en not_active Ceased
- 2020-12-03 CN CN202080095838.7A patent/CN115427558A/zh active Pending
- 2020-12-03 MX MX2022006799A patent/MX2022006799A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12203077B2 (en) | Fusion proteins for improved precision in base editing | |
| AU2018240571B2 (en) | Nucleobase editors comprising nucleic acid programmable DNA binding proteins | |
| CN107109422B (zh) | 使用由两个载体表达的拆分的Cas9的基因组编辑 | |
| US20240401018A1 (en) | Evolved double-stranded dna deaminase base editors and methods of use | |
| WO2021178717A2 (en) | Improved methods and compositions for modulating a genome | |
| JP2022516130A5 (cg-RX-API-DMAC7.html) | ||
| SG11202108303SA (en) | Inhibition of unintended mutations in gene editing | |
| JP2021522783A5 (cg-RX-API-DMAC7.html) | ||
| JP2025510586A5 (cg-RX-API-DMAC7.html) | ||
| JP2022529329A (ja) | 人工的に構築されたrna編集酵素による部位特異的rna編集および関連使用 | |
| KR20180069898A (ko) | 핵염기 편집제 및 그의 용도 | |
| EP4337701A1 (en) | Effector proteins and methods of use | |
| CA3225808A1 (en) | Context-specific adenine base editors and uses thereof | |
| CN114144519B (zh) | 单碱基置换蛋白以及包含其的组合物 | |
| US20250312376A1 (en) | Compositions and methods for modulating a genome in t cells, induced pluripotent stem cells, and respiratory epithelial cells | |
| WO2023250148A1 (en) | Compositions and methods for epigenetic editing | |
| JP2024531607A5 (cg-RX-API-DMAC7.html) | ||
| KR102151064B1 (ko) | 매칭된 5' 뉴클레오타이드를 포함하는 가이드 rna를 포함하는 유전자 교정용 조성물 및 이를 이용한 유전자 교정 방법 | |
| KR102937433B1 (ko) | 표적 특이적 crispr 변이체 | |
| CN120098961A (zh) | 一种具有高活性和高保真性的saCas9蛋白变体及其应用 | |
| CN118649229A (zh) | 工程化Cas9蛋白及其制备方法和应用 | |
| JP2026507559A (ja) | Crisprトランスポゾンシステム及び構成要素 | |
| CN113652411A (zh) | Cas9蛋白、含有Cas9蛋白的基因编辑系统及应用 | |
| US20160138047A1 (en) | Improved polynucleotide sequences encoding tale repeats | |
| WO2023207607A1 (zh) | 用于修饰线粒体dna的脱氨酶突变体、组合物和方法 |